DG
Daventry Group’s Health Catalyst HCAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,509,480
| Closed | -$17.7M | – | 9 |
|
|
2024
Q4 | $17.7M | Buy |
2,509,480
+91,878
| +4% | +$650K | 6.78% | 8 |
|
|
2024
Q3 | $19.7M | Buy |
2,417,602
+170,549
| +8% | +$1.39M | 7.83% | 8 |
|
|
2024
Q2 | $14.4M | Buy |
2,247,053
+84,178
| +4% | +$538K | 6.41% | 8 |
|
|
2024
Q1 | $16.3M | Buy |
2,162,875
+242,500
| +13% | +$1.83M | 6.51% | 7 |
|
|
2023
Q4 | $17.8M | Buy |
1,920,375
+346,200
| +22% | +$3.21M | 7.64% | 8 |
|
|
2023
Q3 | $15.9M | Sell |
1,574,175
-62,936
| -4% | -$637K | 10.16% | 5 |
|
|
2023
Q2 | $20.5M | Hold |
1,637,111
| – | – | 15.15% | 3 |
|
|
2023
Q1 | $19.1M | Buy |
1,637,111
+197,497
| +14% | +$2.3M | 13.37% | 6 |
|
|
2022
Q4 | $15.3M | Buy |
1,439,614
+587,110
| +69% | +$6.24M | 13.21% | 5 |
|
|
2022
Q3 | $8.27M | Hold |
852,504
| – | – | 11.18% | 6 |
|
|
2022
Q2 | $12.4M | Buy |
852,504
+291,743
| +52% | +$4.23M | 16.84% | 2 |
|
|
2022
Q1 | $14.7M | Buy |
560,761
+250,353
| +81% | +$6.54M | 15.24% | 3 |
|
|
2021
Q4 | $12.3M | Buy |
+310,408
| New | +$12.3M | 13.84% | 3 |
|